Lisa Wright - 30 Apr 2025 Form 4 Insider Report for Vericel Corp (VCEL)

Reporting relationship: Director
Issuer ticker: VCEL
Reported as of: 30 Apr 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 May 2025, 16:07:01 UTC
Prior SEC filing: 05 Jun 2024
Next SEC filing: 01 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Sean Flynn, as Attorney-in-Fact for Lisa Wright

Key filing fact

Lisa Wright filed Form 4 for Vericel Corp (VCEL) on 02 May 2025.

Key facts

This page summarizes Lisa Wright's Form 4 filing for Vericel Corp (VCEL).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 02 May 2025, 16:07.

Change

Previous filing in this sequence was filed on 05 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001865017 Primary reporting owner

WRIGHT LISA

Relationship: Director
Address: C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE
Signature: /s/ Sean Flynn, as Attorney-in-Fact for Lisa Wright
Signature date: 02 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCEL transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,200
Change %: +34%
Price
Shares after: 12,651
Date: 30 Apr 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCEL transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: +3,200
Change %
Price
Shares after: 0
Date: 30 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,200
Exercise price
Footnotes: F2, F3, F4, F5

VCEL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +8,000
Change %
Price: $0.000000
Shares after: 8,000
Date: 30 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,000
Exercise price: $38.02
Footnotes: F6

VCEL transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +3,200
Change %
Price: $0.000000
Shares after: 3,200
Date: 30 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,200
Exercise price
Footnotes: F2, F5, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The Restricted Stock Units (RSUs) converted to Phantom Stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date.

Footnote F2

Upon the vesting of RSUs granted to the Reporting Person on May 1, 2024, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan.

Footnote F3

Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

Footnote F4

These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024.

Footnote F5

No expiration date for this type of award.

Footnote F6

The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.

Footnote F7

These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.